首页> 外国专利> METHOD FOR DETERMINATION OF ONSET RISK OF GLAUCOMA.

METHOD FOR DETERMINATION OF ONSET RISK OF GLAUCOMA.

机译:确定青光眼发病风险的方法。

摘要

Disclosed is a method for the determination of presence or absence of the risk of glaucoma, which comprises the steps of: detecting in vitro an allele and/or a genotype of a single nucleotide polymorphism occurring at position-31 in at least one nucleotide sequence selected from the group consisting of the nucleotide sequences depicted in SEQ ID NOs:203-514 or a nucleotide sequence complementary to the at least one nucleotide sequence in a sample collected from a subject (step A); and comparing the allele and/or the genotype detected in the step A with at least one allele and/or genotype containing a high-risk allele in a nucleotide sequence depicted in any one of SEQ ID NOs:203-514 (step B). The level of the onset risk of glaucoma in a donor of a sample can be determined by analyzing the allele or genotype of the single nucleotide polymorphism in the sample by the method. Based on the level of the risk, the donor can adopt a preventive measure for glaucoma or receive a proper treatment for glaucoma.
机译:本发明公开了一种确定是否存在青光眼风险的方法,该方法包括以下步骤:体外检测在至少一个选择的核苷酸序列中在第31位发生的单核苷酸多态性的等位基因和/或基因型。选自由SEQ ID NO:203-514中所示的核苷酸序列或与从受试者收集的样品中的至少一个核苷酸序列互补的核苷酸序列组成的组(步骤A);并将在步骤A中检测到的等位基因和/或基因型与在SEQ ID NOs:203-514中任一所示的核苷酸序列中的至少一个包含高风险等位基因的等位基因和/或基因型进行比较(步骤B)。可以通过分析该方法中样品中单核苷酸多态性的等位基因或基因型来确定样品供体中青光眼的发病风险水平。根据风险程度,供者可以对青光眼采取预防措施或对青光眼进行适当治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号